FLORHAM PARK, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”) a biotechnology company developing allogeneic cell therapies and advanced biomaterial products, ...
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London today announce ...
Neurodegenerative diseases (NDDs), including Alzheimer's Disease and Parkinson's Disease, are among the most common causes of physical and cognitive disability, experienced by approximately 15% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback